BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10372270)

  • 21. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing pharmacologic management of inflammatory bowel disease.
    Chang S; Hanauer S
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):595-607. PubMed ID: 28475384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of steroid-resistant inflammatory bowel disease.
    Manz M; Vavricka SR; Wanner R; Lakatos PL; Rogler G; Frei P; Safroneeva E; Schoepfer AM
    Digestion; 2012; 86 Suppl 1():11-5. PubMed ID: 23051721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Bowel Disease - Non-biological treatment.
    Magro F; Cordeiro G; Dias AM; Estevinho MM
    Pharmacol Res; 2020 Oct; 160():105075. PubMed ID: 32653651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of severe steroid refractory ulcerative colitis.
    Van Assche G; Vermeire S; Rutgeerts P
    World J Gastroenterol; 2008 Sep; 14(36):5508-11. PubMed ID: 18810767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
    Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conservative therapy of inflammatory bowel diseases].
    Nagy F
    Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard immunosuppression in IBD: current practice.
    Feagan BG
    Acta Gastroenterol Belg; 2001; 64(2):182-8. PubMed ID: 11475131
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medical therapy of inflammatory bowel diseases: Crohn's disease].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Jun; 148(24):1107-14. PubMed ID: 17561480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
    Farkas K; Molnár T; Szepes Z
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):695-702. PubMed ID: 24738535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy of inflammatory bowel disease.
    Sack DM; Peppercorn MA
    Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
    Burakoff R
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S202-3. PubMed ID: 18816760
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
    Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
    Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-line therapies in inflammatory bowel disease.
    Girardin M; Manz M; Manser C; Biedermann L; Wanner R; Frei P; Safroneeva E; Mottet C; Rogler G; Schoepfer AM
    Digestion; 2012; 86 Suppl 1():6-10. PubMed ID: 23051720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results.
    Gurudu SR; Griffel LH; Gialanella RJ; Das KM
    J Clin Gastroenterol; 1999 Sep; 29(2):151-4. PubMed ID: 10478875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.